Friends/Alexandria Forum 2013 – A Blueprint for Drug/Diagnostic Co-development: Breakthrough Therapies White Paper | April 7, 2016 Share
Conference on Clinical Cancer Research 2013: Panel Three: Optimizing Dosing of Oncology Drugs | April 7, 2016 Share
Conference on Clinical Cancer Research 2013: Panel One: Facilitating Development of Immunotherapies | April 7, 2016 Share
Friends/Alexandria Forum 2014 – A Blueprint for Drug/Diagnostic Co-development: Next-Generation Sequencing (NGS) White Paper | April 7, 2016 Share
Conference on Clinical Cancer Research 2014: Panel Three – Considerations for Summary Review of Supplemental NDA/BLA Submissions in Oncology | April 7, 2016 Share
Conference on Clinical Cancer Research 2014: Panel Two – Improving Evidence Developed from Population-Level Experience with Targeted Agents | April 7, 2016 Share
Conference on Clinical Cancer Research 2014: Panel One – The Role of Non-Randomized Trials for the Evaluation of Oncology Drugs | April 7, 2016 Share
Friends/Alexandria Forum 2015 – Blueprint for Drug/Diagnostic Development: Genetic Databases White Paper | April 7, 2016 Share
Conference on Clinical Cancer Research 2015: Panel Three – The Blurring of Phase 1, 2 and 3 Trials in Oncology: Expansion Cohorts in Phase 1 Trials | April 7, 2016 Share
Conference on Clinical Cancer Research 2015: Panel Two – Capturing Symptomatic Adverse Events From the Patients’ Perspective: The Potential Role of the National Cancer Institute’s PRO-CTCAE Measurement System | April 7, 2016 Share
